The 2026 DEA Drugs of Abuse guide deleted the line that FDA never approved marijuana. Its own hearing record says state programs aren’t medicine.
The GAO drug scheduling report that paused marijuana rescheduling found DEA has no written policies and FDA uses professional judgment.
A judge paused marijuana rescheduling for two weeks after FDA told federal auditors its two-part test was never meant to be the standard.
The political debate over marijuana may be nowhere near settled. In a new clip from High Stakes, historian and addiction
The Food and Drug Administration will open a public hearing Monday afternoon on how psychedelic drugs should be delivered to
A sweeping new review in The Lancet Psychiatry has reached a conclusion the marijuana industry has spent years working to obscure: there
The wider administration has taken steps to profoundly normalize the drug and open the door to significant further commercialization.
First it was Mehmet Oz, the guru of pseudoscience, who began giving an FDA-unapproved drug—CBD—to Medicare patients.
Despite the industry–and now the federal government–claiming that marijuana has therapeutic benefits, evidence continues to emerge showing that the drug reduces health.
